Barentz Expands in Asia: Acquiring Fengli, Top Pharma Excipients Distributor

Equity Deal Barentz Eyes Chinese Pharma Market with Planned Fengli Group Acquisition

2025-05-26 Source: Barentz 2 min Reading Time

Related Vendors

Barentz

EagleBurgmann Germany GmbH & Co. KG

Italvacuum, Srl

TRM Filter d.o.o.

Barentz aims to expand its presence in Asia by acquiring China-based Fengli Group, a leading distributor of pharmaceutical excipients and APIs. The move would strengthen the company’s foothold in the Chinese pharma market and create new regional growth opportunities.

(from left to right): Gino Thomas Soeriowardojo (Barentz Head of M&A), Marc Duchene (Barentz CEO Asia Pacific), Mrs. May, Derk Jan Terhorst (Barentz Groups CEO), Mr. Ma and Yeffita(Source: Barentz) — (from left to right): Gino Thomas Soeriowardojo (Barentz Head of M&A), Marc Duchene (Barentz CEO Asia Pacific), Mrs. May, Derk Jan Terhorst (Barentz Groups CEO), Mr. Ma and Yeffita
(Source: Barentz)

Dutch speciality ingredients company Barentz has entered into exclusive discussions to acquire 100 % equity of Fengli Group, one of the leading specialty chemicals distributors for pharmaceutical excipients and active ingredients in China.

This intended strategic move would grant Barentz access to the Chinese pharma market and establish a robust sales network centered around innovative excipients and active pharma ingredients (APIs). The partnership would further enhance the service and commercial capabilities of Barentz in China while enabling Fengli Group to expand its international presence. By aligning product portfolios, both companies are set to unlock significant synergies and drive accelerated growth.

Derk Jan Terhorst, Group CEO at Barentz said: “This envisaged acquisition would mean a transformative step for Barentz in the Asia Pacific region and fully aligns with our strategic ambition to expand and strengthen our global presence. Fengli Group’s strong local reputation and established network provide an excellent foundation for growth. Under Mr. Ma’s continued leadership, we are set to accelerate our expansion, reinforcing our commitment to the pharmaceutical and health product market in Asia Pacific and beyond. The transaction would also create pan-regional opportunities, enabling us to expand our principal partnerships beyond China and further solidify our regional presence.”

Established in 1996 and headquartered in Beijing, Fengli Group comprises a team of over 100 professionals across five locations in China. It sources pharmaceutical excipients and active ingredients from 35 international principals and serves more than 2000 customers in pharmaceutical production, research, and development. Fengli Group's primary focus is on the pharma and health product markets in mainland China. Their facilities include an analytical pharma lab for product formulation and support, as well as excipient research, development, and application labs.

The parties expect to complete the acquisition during the second half of 2025, with completion subject to customary closing conditions and regulatory clearances.

(ID:50433520)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.